Drug Name |
|
Synonyms |
GSK 089; GSK 1363089; GSK1363089; XL 880; GSK1363089, GSK089, foretinib, EXEL-2880, XL880; 88Z; MET inhibitors
|
Indication |
Disease Entry |
ICD 11 |
Status |
REF |
Breast cancer |
2C60-2C65 |
Phase 2 |
[1]
|
Gastric adenocarcinoma |
2B72 |
Phase 2 |
[2]
,
[3]
|
Renal cell carcinoma |
2C90 |
Phase 2 |
[2]
,
[3]
|
Squamous head and neck cell carcinom |
2D60.0 |
Phase 2 |
[2]
,
[3]
|
Solid tumour/cancer |
2A00-2F9Z |
Phase 1 |
[2]
,
[3]
|
|
|
Therapeutic Class |
Anticancer Agents
|
Cross-matching ID |
- PubChem CID
- 42642645
- ChEBI ID
-
CHEBI:91418
- CAS Number
-
CAS 849217-64-7
- TTD Drug ID
- DMHJTR2
|
|
|
|
|
|
|
|